$CSCIF

$5.16 -$0.34 (6.18%) Close

$CSCIF Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 3.2M shares outstanding

Who owns CSCIF?

By type of holder

Institutions 0.0% Everyone else 100.0%

No insider has reported a holding in the last two years, so insiders are counted in "Everyone else".

Concentration Top 3 holders own 9.1%

Goodwood Inc. 8.1% · Peter Puccetti 0.5%

Institutional ownership

0.0%

0.0 pts vs last qtr

Institutional holders

0 vs last qtr

Net shares bought

by institutions in Q2 2026

New / sold out

0 / 0

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

None.

Biggest sellers in Q2 2026

None.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for COSCIENS Biopharma Inc in the last 12 months.

Is your stake being diluted?

There are not yet two fiscal years of reported share counts for COSCIENS Biopharma Inc.

How patient are the owners?

No 13F manager reports holding CSCIF.

Super Investors

Investment managers reporting CSCIF on Form 13F

No 13F manager reports holding CSCIF yet.

Institutional Funds

Mutual funds and ETFs reporting CSCIF on Form N-PORT; together they hold 0.0% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
FN Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust	$778	278	0.01%	0.00%	February 28, 2025

Fidelity Nasdaq Composite Index Fund

Fidelity Concord Street Trust

Position value

$778

% of company

0.01%

% of the fund

0.00%

As of

February 28, 2025

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
G Goodwood Inc. 5%+ holder 13D · 8.2%	257.3K	8.08%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company8.080% Disclosed stake13D · 8.2% View the 13D/G filing →
PP Peter Puccetti 5%+ holder 13D · 0.5%	15.7K	0.49%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company0.490% Disclosed stake13D · 0.5% View the 13D/G filing →

Goodwood Inc.

5%+ holder13D · 8.2%

257.3K

% of company

8.08%

Change vs last qtr

—

Held since

—

Peter Puccetti

5%+ holder13D · 0.5%

15.7K

% of company

0.49%

Change vs last qtr

—

Held since

—

1 more holders behind a free account

See every insider and 5%+ holder of COSCIENS Biopharma Inc.

Comments